Related Experiment Video
Updated: Jul 1, 2026

Long-term Sensory Conflict in Freely Behaving Mice
Published on: February 20, 2019
Susceptibility genes for gentamicin-induced vestibular dysfunction
Stephen M Roth1, Scott M Williams, Lan Jiang
1Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742-2611, USA. sroth1@umd.edu
Background:
Approximately 5% of patients administered gentamicin (GM), an aminoglycoside antibiotic, experience vestibular ototoxicity resulting in balance dysfunction. In the present study, we sought to identify susceptibility genes associated with GM-induced vestibular dysfunction using a case/control design.
Methods:
White cases (n=137; 55 men, 82 women) were recruited based on physician-confirmed unilateral or bilateral vestibular dysfunction attributed to GM administration. Controls (n=126; 54 men, 72 women) were healthy, age-matched individuals without vestibular dysfunction or balance impairment. Buccal cell samples were obtained from all subjects and DNA was genotyped for 15 polymorphisms in 9 genes. Candidate genes were identified primarily for their roles in oxidative stress based on predicted mechanisms of gentamicin-induced ototoxicity. Statistical analyses included the multi-dimensionality reduction (MDR) method for identifying gene x gene interactions across multiple candidate genes.
Results:
Both single gene and MDR analyses revealed the NOS3 (ENOS) p.Glu298Asp polymorphism as significantly associated with GM-induced vestibular dysfunction (both p
Conclusions:
The results indicate that carriers of risk alleles at three oxidative stress-related genes have increased susceptibility to GM-induced vestibular dysfunction.
Insights
Gentamicin (GM) antibiotic use can cause vestibular ototoxicity. Genetic variations in NOS3, GSTZ1, and GSTP1 genes increase susceptibility to GM-induced balance dysfunction, particularly in carriers of specific risk alleles.
Area of Science:
- Pharmacogenomics
- Neuroscience
- Genetics
Background:
- Gentamicin (GM), an aminoglycoside antibiotic, can cause vestibular ototoxicity in approximately 5% of patients, leading to balance dysfunction.
- Identifying genetic factors influencing susceptibility to GM-induced ototoxicity is crucial for personalized medicine and risk mitigation.
Purpose of the Study:
- To identify specific gene polymorphisms associated with gentamicin-induced vestibular dysfunction.
- To explore gene-gene interactions that may predict susceptibility to this adverse drug reaction.
Main Methods:
- A case/control study design was employed, comparing patients with GM-induced vestibular dysfunction (cases) to healthy controls.
- DNA from 137 cases and 126 controls was genotyped for 15 polymorphisms in 9 candidate genes, focusing on those involved in oxidative stress pathways.
- Statistical analyses included single-gene association tests and multi-dimensionality reduction (MDR) to identify gene-gene interactions.
Main Results:
- The NOS3 (ENOS) p.Glu298Asp polymorphism was significantly associated with GM-induced vestibular dysfunction (p ≤ 0.03).
- A three-gene combination (NOS3, GSTZ1, GSTP1) using MDR analysis demonstrated the highest predictive accuracy (64%, p=0.009) for GM-induced vestibular dysfunction.
Conclusions:
- Genetic variations in oxidative stress-related genes, specifically NOS3, GSTZ1, and GSTP1, are linked to increased susceptibility to gentamicin-induced vestibular ototoxicity.
- Carriers of risk alleles in these genes may be at higher risk for developing balance dysfunction after GM administration.
Related Concept Videos
Equilibrium and Balance
The Vestibular System
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Mechanism of Antibiotic Resistance in MRSA

